216 related articles for article (PubMed ID: 35636512)
1. mTORC1-independent translation control in mammalian cells by methionine adenosyltransferase 2A and S-adenosylmethionine.
Alam M; Shima H; Matsuo Y; Long NC; Matsumoto M; Ishii Y; Sato N; Sugiyama T; Nobuta R; Hashimoto S; Liu L; Kaneko MK; Kato Y; Inada T; Igarashi K
J Biol Chem; 2022 Jul; 298(7):102084. PubMed ID: 35636512
[TBL] [Abstract][Full Text] [Related]
2. mTORC1 stimulates cell growth through SAM synthesis and m
Villa E; Sahu U; O'Hara BP; Ali ES; Helmin KA; Asara JM; Gao P; Singer BD; Ben-Sahra I
Mol Cell; 2021 May; 81(10):2076-2093.e9. PubMed ID: 33756106
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
4. S-Adenosylmethionine Synthesis Is Regulated by Selective N
Shima H; Matsumoto M; Ishigami Y; Ebina M; Muto A; Sato Y; Kumagai S; Ochiai K; Suzuki T; Igarashi K
Cell Rep; 2017 Dec; 21(12):3354-3363. PubMed ID: 29262316
[TBL] [Abstract][Full Text] [Related]
5. Targeting the methionine-methionine adenosyl transferase 2A- S -adenosyl methionine axis for cancer therapy.
Guo J; Yang Y; Buettner R; Rosen ST
Curr Opin Oncol; 2022 Sep; 34(5):546-551. PubMed ID: 35788128
[TBL] [Abstract][Full Text] [Related]
6. Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer.
Yang H; Huang ZZ; Zeng Z; Chen C; Selby RR; Lu SC
Am J Physiol Gastrointest Liver Physiol; 2001 Feb; 280(2):G184-90. PubMed ID: 11208539
[TBL] [Abstract][Full Text] [Related]
7. S-adenosyl-L-methionine modifies antioxidant-enzymes, glutathione-biosynthesis and methionine adenosyltransferases-1/2 in hepatitis C virus-expressing cells.
Lozano-Sepulveda SA; Bautista-Osorio E; Merino-Mascorro JA; Varela-Rey M; Muñoz-Espinosa LE; Cordero-Perez P; Martinez-Chantar ML; Rivas-Estilla AM
World J Gastroenterol; 2016 Apr; 22(14):3746-57. PubMed ID: 27076759
[TBL] [Abstract][Full Text] [Related]
8. S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells.
Strekalova E; Malin D; Weisenhorn EMM; Russell JD; Hoelper D; Jain A; Coon JJ; Lewis PW; Cryns VL
Breast Cancer Res Treat; 2019 May; 175(1):39-50. PubMed ID: 30712196
[TBL] [Abstract][Full Text] [Related]
9. Overview of Methionine Adenosyltransferase 2A (MAT2A) as an Anticancer Target: Structure, Function, and Inhibitors.
Li C; Gui G; Zhang L; Qin A; Zhou C; Zha X
J Med Chem; 2022 Jul; 65(14):9531-9547. PubMed ID: 35796517
[TBL] [Abstract][Full Text] [Related]
10. Low-dose methotrexate inhibits methionine S-adenosyltransferase in vitro and in vivo.
Wang YC; Chiang EP
Mol Med; 2012 May; 18(1):423-32. PubMed ID: 22193356
[TBL] [Abstract][Full Text] [Related]
11. S-adenosylmethionine limitation induces p38 mitogen-activated protein kinase and triggers cell cycle arrest in G1.
Lin DW; Chung BP; Kaiser P
J Cell Sci; 2014 Jan; 127(Pt 1):50-9. PubMed ID: 24155332
[TBL] [Abstract][Full Text] [Related]
12. HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis.
Vázquez-Chantada M; Fernández-Ramos D; Embade N; Martínez-Lopez N; Varela-Rey M; Woodhoo A; Luka Z; Wagner C; Anglim PP; Finnell RH; Caballería J; Laird-Offringa IA; Gorospe M; Lu SC; Mato JM; Martínez-Chantar ML
Gastroenterology; 2010 May; 138(5):1943-53. PubMed ID: 20102719
[TBL] [Abstract][Full Text] [Related]
13. L-methionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells: role of S-adenosylmethionine.
Martínez-Chantar ML; Latasa MU; Varela-Rey M; Lu SC; García-Trevijano ER; Mato JM; Avila MA
J Biol Chem; 2003 May; 278(22):19885-90. PubMed ID: 12660248
[TBL] [Abstract][Full Text] [Related]
14. The U6 snRNA m
Pendleton KE; Chen B; Liu K; Hunter OV; Xie Y; Tu BP; Conrad NK
Cell; 2017 May; 169(5):824-835.e14. PubMed ID: 28525753
[TBL] [Abstract][Full Text] [Related]
15. Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
Frau M; Tomasi ML; Simile MM; Demartis MI; Salis F; Latte G; Calvisi DF; Seddaiu MA; Daino L; Feo CF; Brozzetti S; Solinas G; Yamashita S; Ushijima T; Feo F; Pascale RM
Hepatology; 2012 Jul; 56(1):165-75. PubMed ID: 22318685
[TBL] [Abstract][Full Text] [Related]
16. Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis.
Wang X; Guo X; Yu W; Li C; Gui Y; Cai Z
BMC Cancer; 2014 Mar; 14():196. PubMed ID: 24636201
[TBL] [Abstract][Full Text] [Related]
17. CBS and MAT2A improve methionine-mediated DNA synthesis through SAMTOR/mTORC1/S6K1/CAD pathway during embryo implantation.
Cai S; Ye Q; Zeng X; Yang G; Ye C; Chen M; Yu H; Wang Y; Wang G; Huang S; Quan S; Zeng X; Qiao S
Cell Prolif; 2021 Jan; 54(1):e12950. PubMed ID: 33179842
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells.
Cai J; Mao Z; Hwang JJ; Lu SC
Cancer Res; 1998 Apr; 58(7):1444-50. PubMed ID: 9537246
[TBL] [Abstract][Full Text] [Related]
19. Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A.
Quinlan CL; Kaiser SE; Bolaños B; Nowlin D; Grantner R; Karlicek-Bryant S; Feng JL; Jenkinson S; Freeman-Cook K; Dann SG; Wang X; Wells PA; Fantin VR; Stewart AE; Grant SK
Nat Chem Biol; 2017 Jul; 13(7):785-792. PubMed ID: 28553945
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of thioacetamide on hepatic methionine adenosyltransferase expression in the rat.
Huang ZZ; Mato JM; Kanel G; Lu SC
Hepatology; 1999 May; 29(5):1471-8. PubMed ID: 10216131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
